BOT 8.70% 31.5¢ botanix pharmaceuticals ltd

Ann: New Territory Licensed for Sofpironium Bromide with Kaken, page-16

  1. 4,386 Posts.
    lightbulb Created with Sketch. 1348
    BOT receives 25% of the royalty payments that Brickell receive I believe in the original agreement.

    This will start to add up in future years from Asian markets obviously.

    Good to see another diversified pipeline coming through.

    The real gold here is the FDA approval, which will automatically bring Europe in amongst other markets.

    BOT have indicated this is not material as compared to revenue from the USA it won't be, but obviously it is "unknown" at this stage.

    About time people grabbed a few under 10c imo.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
-0.030(8.70%)
Mkt cap ! $570.1M
Open High Low Value Volume
34.5¢ 34.5¢ 31.5¢ $6.354M 19.19M

Buyers (Bids)

No. Vol. Price($)
13 286322 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 28500 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.